Skip to main content
main-content

Latest news

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Islet transplantation benefits endure over 10 years

Islet cells

Three-quarters of people who undergo islet transplantation for type 1 diabetes have sustained graft survival with associated improvements in glucose control, insulin requirements, and hypoglycemia incidence 10 years later, research shows.

CGM time in range: A higher standard for an engaged few?

CGM_action

Simon Heller explains why time-in-range targets are so helpful for people with diabetes… yet handing out continuous glucose monitoring devices willy-nilly could do more harm than good.

Latest headlines

18-10-2019 | Ketoacidosis | News

Off-label SGLT2 inhibitor use linked to higher than expected DKA rates

Real-world, off-label sodium–glucose cotransporter 2 inhibitor use is uncommon in people with type 1 diabetes but appears to be associated with a higher than expected rate of diabetic ketoacidosis when compared with clinical trials, US researchers report.

16-10-2019 | Artificial pancreas systems | News

iDCL trial shows sustained time in range improvement with hybrid closed-loop delivery

People with type 1 diabetes using the Tandem Control-IQ hybrid closed-loop insulin delivery system spent significantly more time within their target blood glucose range than people using a sensor-augmented insulin pump during 6 months of use in the iDCL trial.

15-10-2019 | Glycemic control | News

Less stringent glycemic control targets may benefit older people with long type 2 diabetes history

The effect of glycemic control on all‐cause mortality risk depends on diabetes duration in people aged 65 years and older with type 2 diabetes, study findings indicate.

Features and expert interviews

16-10-2019 | Continuous glucose monitoring | Feature | Article

CGM time in range: A higher standard for an engaged few?

Simon Heller explains why time-in-range targets are so helpful for people with diabetes… yet handing out continuous glucose monitoring devices willy-nilly could do more harm than good.

24-07-2019 | Artificial pancreas systems | Feature | Article

Adaptive and flexible: Closed-loop technology for all

medwireNews talks to one of the pioneers of closed-loop insulin delivery, Roman Hovorka, about his algorithm, his research so far, and his plans for commercialization.

17-07-2019 | Artificial pancreas systems | Feature | Article

The artificial pancreas: What’s on the horizon?

medwireNews talks to Dan Finan from the JDRF about the artificial pancreas systems already in the pipeline, and how these are evolving in ways that might benefit particular groups of people with diabetes.

Image Credits